Wells Fargo’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-800
Closed -$27K 7349
2022
Q2
$27K Sell
800
-200
-20% -$8.49K ﹤0.01% 5302
2022
Q1
$72K Sell
1,000
-17,200
-95% -$1.24M ﹤0.01% 5476
2021
Q4
$1.69M Buy
18,200
+17,400
+2,175% +$2.08M ﹤0.01% 3659
2021
Q3
$101K Hold
800
﹤0.01% 5383
2021
Q2
$133K Hold
800
﹤0.01% 5183
2021
Q1
$145K Buy
+800
New +$186K ﹤0.01% 5312

Other funds holding TDOC

Wells Fargo's TDOC Position: Q1 2026 in Review

Wells Fargo increased its Teladoc Health (TDOC) stake by 3.9% in Q1 2026, buying an estimated $58.1K and bringing the position to 277,073 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

Wells Fargo first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $134M in Q4 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Wells Fargo held 277,073 shares of Teladoc Health worth $1.51M as of Q1 2026.
  • Wells Fargo bought 10,363 Teladoc Health shares in Q1 2026, an estimated $58.1K.
  • Teladoc Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3487 holding.
  • Wells Fargo first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
  • Wells Fargo's Teladoc Health position peaked at $134M in Q4 2020.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.